Yossi Maimon

Protalix BioTherapeutics

Vice President, Chief Financial Officer

Overview

Yossi Maimon made an average of $649.5K in compensation at Protalix BioTherapeutics from 2006 to 2018.

Annual data

2018

In 2018, Yossi Maimon earned a total compensation of $557.6K as Vice President, Chief Financial Officer at Protalix BioTherapeutics.

Ranking7,042 out of 8,301
Percentile15.2%

Yossi Maimon's 2018 compensation ranked 7,042nd out of 8,301 executive pay records tracked by us this year.

Maimon earned more than 15.2% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking469 out of 542
Percentile13.5%

In the industry group of Drugs, Maimon's pay ranked 469th out of 542 executive pay records tracked by us in 2018.

Maimon earned more than 13.5% of executives in this group.

Bonus$140,000
Option Awards$59,089
Salary$282,649
Other$75,813
Total$557,551

Maimon received $282.6K in salary, which accounts for 50.69% of total compensation.

Maimon also received $140K in bonus, $59.1K in option awards and $75.8K in other compensation.

Yossi Maimon's Pay$557,551
Median Employee's Pay$47,782
Pay Ratio12 : 1

For fiscal year 2018, the annual total compensation for Yossi Maimon was $557,551 and for the median employee at Protalix BioTherapeutics was $47,782. The resulting ratio of Yossi Maimon's pay to the pay of median employee was 12 to one.

2017

In 2017, Yossi Maimon earned a total compensation of $759K as Vice President, Chief Financial Officer at Protalix BioTherapeutics.

Ranking9,294 out of 13,165
Percentile29.4%

Yossi Maimon's 2017 compensation ranked 9,294th out of 13,165 executive pay records tracked by us this year.

Maimon earned more than 29.4% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking948 out of 1,395
Percentile32.0%

In the industry group of Drugs, Maimon's pay ranked 948th out of 1,395 executive pay records tracked by us in 2017.

Maimon earned more than 32.0% of executives in this group.

Bonus$363,647
Option Awards$37,686
Salary$282,197
Other$75,448
Total$758,978

Maimon received $363.6K in bonus, which accounts for 47.91% of total compensation.

Maimon also received $37.7K in option awards, $282.2K in salary and $75.4K in other compensation.

2016

In 2016, Yossi Maimon earned a total compensation of $444.8K as Vice President, Chief Financial Officer at Protalix BioTherapeutics.

Ranking11,416 out of 13,853
Percentile17.6%

Yossi Maimon's 2016 compensation ranked 11,416th out of 13,853 executive pay records tracked by us this year.

Maimon earned more than 17.6% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking1,254 out of 1,472
Percentile14.8%

In the industry group of Drugs, Maimon's pay ranked 1,254th out of 1,472 executive pay records tracked by us in 2016.

Maimon earned more than 14.8% of executives in this group.

Option Awards$93,890
Salary$264,696
Stock Awards$16,043
Other$70,153
Total$444,782

Maimon received $264.7K in salary, which accounts for 59.51% of total compensation.

Maimon also received $93.9K in option awards, $16K in stock awards and $70.2K in other compensation.

2015

In 2015, Yossi Maimon earned a total compensation of $780.5K as Vice President, Chief Financial Officer at Protalix BioTherapeutics.

Ranking9,067 out of 13,574
Percentile33.2%

Yossi Maimon's 2015 compensation ranked 9,067th out of 13,574 executive pay records tracked by us this year.

Maimon earned more than 33.2% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking1,004 out of 1,484
Percentile32.3%

In the industry group of Drugs, Maimon's pay ranked 1,004th out of 1,484 executive pay records tracked by us in 2015.

Maimon earned more than 32.3% of executives in this group.

Bonus$246,009
Option Awards$102,215
Salary$266,776
Stock Awards$97,120
Other$68,398
Total$780,518

Maimon received $266.8K in salary, which accounts for 34.18% of total compensation.

Maimon also received $246K in bonus, $102.2K in option awards, $97.1K in stock awards and $68.4K in other compensation.

2014

In 2014, Yossi Maimon earned a total compensation of $860K as Vice President, Chief Financial Officer at Protalix BioTherapeutics.

Ranking8,175 out of 12,876
Percentile36.5%

Yossi Maimon's 2014 compensation ranked 8,175th out of 12,876 executive pay records tracked by us this year.

Maimon earned more than 36.5% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking794 out of 1,310
Percentile39.4%

In the industry group of Drugs, Maimon's pay ranked 794th out of 1,310 executive pay records tracked by us in 2014.

Maimon earned more than 39.4% of executives in this group.

Bonus$225,000
Option Awards$56,170
Salary$299,090
Stock Awards$205,244
Other$74,493
Total$859,997

Maimon received $299.1K in salary, which accounts for 34.78% of total compensation.

Maimon also received $225K in bonus, $56.2K in option awards, $205.2K in stock awards and $74.5K in other compensation.

2013

In 2013, Yossi Maimon earned a total compensation of $974.8K as Vice President, Chief Financial Officer at Protalix BioTherapeutics.

Ranking6,620 out of 11,965
Percentile44.7%

Yossi Maimon's 2013 compensation ranked 6,620th out of 11,965 executive pay records tracked by us this year.

Maimon earned more than 44.7% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking507 out of 1,095
Percentile53.7%

In the industry group of Drugs, Maimon's pay ranked 507th out of 1,095 executive pay records tracked by us in 2013.

Maimon earned more than 53.7% of executives in this group.

Bonus$110,000
Option Awards$126,208
Salary$292,096
Stock Awards$378,745
Other$67,739
Total$974,788

Maimon received $378.7K in stock awards, which accounts for 38.85% of total compensation.

Maimon also received $110K in bonus, $126.2K in option awards, $292.1K in salary and $67.7K in other compensation.

2012

In 2012, Yossi Maimon earned a total compensation of $1.4M as Vice President, Chief Financial Officer at Protalix BioTherapeutics.

Ranking4,725 out of 10,949
Percentile56.8%

Yossi Maimon's 2012 compensation ranked 4,725th out of 10,949 executive pay records tracked by us this year.

Maimon earned more than 56.8% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking246 out of 850
Percentile71.1%

In the industry group of Drugs, Maimon's pay ranked 246th out of 850 executive pay records tracked by us in 2012.

Maimon earned more than 71.1% of executives in this group.

Bonus$157,500
Option Awards$544,199
Salary$268,618
Stock Awards$361,048
Other$58,231
Total$1,389,596

Maimon received $544.2K in option awards, which accounts for 39.16% of total compensation.

Maimon also received $157.5K in bonus, $268.6K in salary, $361K in stock awards and $58.2K in other compensation.

2011

In 2011, Yossi Maimon earned a total compensation of $373.8K as Vice President, Chief Financial Officer at Protalix BioTherapeutics.

Ranking8,432 out of 10,035
Percentile16.0%

Yossi Maimon's 2011 compensation ranked 8,432nd out of 10,035 executive pay records tracked by us this year.

Maimon earned more than 16.0% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking577 out of 705
Percentile18.2%

In the industry group of Drugs, Maimon's pay ranked 577th out of 705 executive pay records tracked by us in 2011.

Maimon earned more than 18.2% of executives in this group.

Option Awards$18,304
Salary$286,220
Other$69,290
Total$373,814

Maimon received $286.2K in salary, which accounts for 76.57% of total compensation.

Maimon also received $18.3K in option awards and $69.3K in other compensation.

2010

In 2010, Yossi Maimon earned a total compensation of $419.5K as Vice President, Chief Financial Officer at Protalix BioTherapeutics.

Ranking7,673 out of 9,477
Percentile19.0%

Yossi Maimon's 2010 compensation ranked 7,673rd out of 9,477 executive pay records tracked by us this year.

Maimon earned more than 19.0% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking496 out of 619
Percentile19.9%

In the industry group of Drugs, Maimon's pay ranked 496th out of 619 executive pay records tracked by us in 2010.

Maimon earned more than 19.9% of executives in this group.

Bonus$20,000
Option Awards$63,175
Salary$268,154
Other$68,156
Total$419,485

Maimon received $268.2K in salary, which accounts for 63.92% of total compensation.

Maimon also received $20K in bonus, $63.2K in option awards and $68.2K in other compensation.

2009

In 2009, Yossi Maimon earned a total compensation of $640.6K as Vice President, Chief Financial Officer at Protalix BioTherapeutics.

Ranking5,465 out of 8,703
Percentile37.2%

Yossi Maimon's 2009 compensation ranked 5,465th out of 8,703 executive pay records tracked by us this year.

Maimon earned more than 37.2% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking295 out of 583
Percentile49.4%

In the industry group of Drugs, Maimon's pay ranked 295th out of 583 executive pay records tracked by us in 2009.

Maimon earned more than 49.4% of executives in this group.

Bonus$160,000
Option Awards$253,030
Salary$186,478
Other$41,051
Total$640,559

Maimon received $253K in option awards, which accounts for 39.50% of total compensation.

Maimon also received $160K in bonus, $186.5K in salary and $41.1K in other compensation.

2008

In 2008, Yossi Maimon earned a total compensation of $555.8K as Vice President, Chief Financial Officer at Protalix BioTherapeutics.

Ranking5,437 out of 7,730
Percentile29.7%

Yossi Maimon's 2008 compensation ranked 5,437th out of 7,730 executive pay records tracked by us this year.

Maimon earned more than 29.7% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking314 out of 542
Percentile42.1%

In the industry group of Drugs, Maimon's pay ranked 314th out of 542 executive pay records tracked by us in 2008.

Maimon earned more than 42.1% of executives in this group.

Bonus$30,659
Option Awards$238,194
Salary$203,097
Other$83,808
Total$555,758

Maimon received $238.2K in option awards, which accounts for 42.86% of total compensation.

Maimon also received $30.7K in bonus, $203.1K in salary and $83.8K in other compensation.

2007

In 2007, Yossi Maimon earned a total compensation of $523.5K as Chief Financial Officer at Protalix BioTherapeutics.

Ranking4,972 out of 6,983
Percentile28.8%

Yossi Maimon's 2007 compensation ranked 4,972nd out of 6,983 executive pay records tracked by us this year.

Maimon earned more than 28.8% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking306 out of 467
Percentile34.5%

In the industry group of Drugs, Maimon's pay ranked 306th out of 467 executive pay records tracked by us in 2007.

Maimon earned more than 34.5% of executives in this group.

Bonus$77,223
Option Awards$247,815
Salary$156,444
Other$41,975
Total$523,457

Maimon received $247.8K in option awards, which accounts for 47.34% of total compensation.

Maimon also received $77.2K in bonus, $156.4K in salary and $42K in other compensation.

2006

In 2006, Yossi Maimon earned a total compensation of $164.5K as Chief Financial Officer at Protalix BioTherapeutics.

Ranking5,107 out of 5,364
Percentile4.8%

Yossi Maimon's 2006 compensation ranked 5,107th out of 5,364 executive pay records tracked by us this year.

Maimon earned more than 4.8% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking404 out of 431
Percentile6.3%

In the industry group of Drugs, Maimon's pay ranked 404th out of 431 executive pay records tracked by us in 2006.

Maimon earned more than 6.3% of executives in this group.

Bonus$31,953
Option Awards$96,712
Salary$27,746
Other$8,077
Total$164,488

Maimon received $96.7K in option awards, which accounts for 58.80% of total compensation.

Maimon also received $32K in bonus, $27.7K in salary and $8.1K in other compensation.